Quanterix (QTRX) EPS (Diluted) Growth (3y) (2022 - 2026)
Quanterix (QTRX) EPS (Diluted) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 18.07% |
| 10 | Quanterix | 148.34 Mn | 54.81 Mn | 12.67 Mn | -91.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -91.36% |
| Mar 31, 2026 | -24.20% |
| Dec 31, 2025 | -3.29% |
| Sep 30, 2025 | 9.68% |
| Jun 30, 2025 | -1.93% |
| Mar 31, 2025 | -2.88% |
| Dec 31, 2024 | 15.19% |
| Sep 30, 2024 | 20.28% |
| Jun 30, 2024 | 16.19% |
| Mar 31, 2024 | 0.07% |
| Dec 31, 2023 | 10.94% |
| Sep 30, 2023 | -65.60% |
| Jun 30, 2023 | 30.15% |
| Mar 31, 2023 | 22.09% |
| Dec 31, 2022 | -4.05% |
| Sep 30, 2022 | -38.64% |